Hif1α is also activated in response to high glucose via ChREBP [39], which aligns with an increased risk of developing RCC in diabetes mellitus but makes the finding of increased tumorigenesis in ChREBP-KO mice more surprising. Here, MLXIPL is linked to diabetes mellitus.